Non-vitamin K antagonist oral anticoagulants and the gastrointestinal bleeding risk in real-world studies

L Anghel, R Sascău, A Trifan, IM Zota… - Journal of clinical …, 2020 - mdpi.com
In the present study, we aimed to provide evidence from high-quality real world studies for a
comprehensive and rigorous analysis on the gastrointestinal bleeding (GIB) risk for non …

Management of direct oral anticoagulants in patients with atrial fibrillation undergoing cardioversion

G Coppola, G Manno, A Mignano, M Luparelli… - Medicina, 2019 - mdpi.com
Atrial fibrillation the most common cardiac arrhythmia. Its incidence rises steadily with each
decade, becoming a real “epidemic phenomenon”. Cardioversion is defined as a rhythm …

[HTML][HTML] Early Diagnosis of Atrial Fibrillation Episodes: Comparative Analysis of Different Matrix Architectures

NW Qammar, A Vainoras, Z Navickas, G Jaruševičius… - Applied Sciences, 2024 - mdpi.com
This study presents three different matrix architectures for the analysis of ECG parameters,
aimed at detecting atrial fibrillation episodes. The evaluation involves a cohort of 15 …

The influence of extremely high body weight (BMI> 35kg/m2) on apixaban plasma concentration in patients with atrial fibrillation

M Hilu, R Colodner, H Eitam, GR Avraham, KC Ram… - 2022 - researchsquare.com
The in uence of extremely high body weight (BMI > 35kg/ m2) on apixaban plasma
concentration in patients with atrial brillati Page 1 Page 1/14 The in uence of extremely high …